A PHASE I STUDY OF AT-101 PLUS RADIOTHERAPY AND TEMOZOLOMIDE AND AT-101 PLUS ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME

被引:0
|
作者
Fiveash, John
Nabors, Louis B.
Mikkelsen, Tom
Peereboom, David M.
Lesser, Glenn J.
Chowdhary, Sajeel A.
Grossman, Stuart
Ye, Xiaubu
Leopold, Lance
Rosenfeld, Myrna
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
下载
收藏
页码:666 / 666
页数:1
相关论文
共 50 条
  • [41] Phase I/Pharmacokinetic study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed Glioblastoma Multiforme (GBM) or Gliosarcoma (GS)
    Butowski, Nicholas
    Lamborn, Kathleen
    Chang, Susan
    DeBoer, Rebecca
    Page, Margaretta
    Rabbitt, Jane
    Fedoroff, Ann
    Parvataneni, Rupa
    Kivett, Valene
    Nicol, Steuen J.
    Musib, Luna
    Leipa, Astra
    Thornton, Donald
    Prados, Michael
    NEUROLOGY, 2008, 70 (11) : A295 - A296
  • [42] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Alonso-Basanta, Michelle
    Fang, Penny
    Maity, Amit
    Hahn, Stephen M.
    Lustig, Robert A.
    Dorsey, Jay F.
    JOURNAL OF NEURO-ONCOLOGY, 2014, 116 (02) : 365 - 372
  • [43] RADIOTHERAPY plus /- TEMOZOLOMIDE IN ELDERLY PATIENTS WITH GLIOBLASTOMA
    Niyazi, M.
    Schwarz, S.
    Suchorska, B.
    Kreth, F. W.
    Tonn, J. C.
    Belka, C.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S368 - S368
  • [44] A phase I study of nelfinavir concurrent with temozolomide and radiotherapy in patients with glioblastoma multiforme
    Michelle Alonso-Basanta
    Penny Fang
    Amit Maity
    Stephen M. Hahn
    Robert A. Lustig
    Jay F. Dorsey
    Journal of Neuro-Oncology, 2014, 116 : 365 - 372
  • [45] RADIOTHERAPY WITH CONCOMITANT AND ADJUVANT TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME PATIENTS: A PROSPECTIVE STUDY
    Sarihan, S.
    Yildirim, S.
    Ozturk, H.
    Evrensel, T.
    Kocaeli, H.
    Tolunay, S.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S216 - S216
  • [46] Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
    Butowski, Nicholas
    Chang, Susan M.
    Lamborn, Kathleen R.
    Polley, Mei-Yin
    Pieper, Russell
    Costello, Joseph F.
    Vandenberg, Scott
    Parvataneni, Rupa
    Nicole, Angelina
    Sneed, Patricia K.
    Clarke, Jennifer
    Hsieh, Emily
    Costa, Bruno M.
    Reis, Rui M.
    Hristova-Kazmierski, Maria
    Nicol, Steven J.
    Thornton, Donald E.
    Prados, Michael D.
    NEURO-ONCOLOGY, 2011, 13 (12) : 1331 - 1338
  • [47] Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiforme
    Ammirati, Mario
    Chotai, Silky
    Newton, Herbert
    Lamki, Tarig
    Wei, Lai
    Grecula, John
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (04) : 633 - 637
  • [48] PHASE II TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Ney, Douglas
    Waziri, Allen
    Lillehei, Kevin
    Kavanagh, Brian D.
    NEURO-ONCOLOGY, 2011, 13 : 128 - 128
  • [49] Bevacizumab in Combination With Radiotherapy and Temozolomide for PatientsWith Newly Diagnosed Glioblastoma Multiforme
    van Linde, Myra E.
    Verhoeff, Joost J. C.
    Richel, Dirk J.
    van Furth, Bwouter R.
    Reijneveld, Jaap C.
    Verheul, Henk M. W.
    Stalpers, Lukas J. A.
    ONCOLOGIST, 2015, 20 (02): : 107 - 108
  • [50] PHASE I TRIAL OF HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY WITH TEMOZOLOMIDE CHEMOTHERAPY FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME
    Chen, Changhu
    Damek, Denise
    Gaspar, Laurie E.
    Waziri, Allen
    Lillehei, Kevin
    Kleinschmidt-DeMasters, B. K.
    Robischon, Monica
    Stuhr, Kelly
    Rusthoven, Kyle E.
    Kavanagh, Brian D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1066 - 1074